Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Malaysia Device, Drug Markets To Grow Despite Economic Crisis

This article was originally published in PharmAsia News

Executive Summary

The demand for medical devices and pharmaceuticals is expected to remain strong enough for the health care industry in Malaysia to weather the global financial crisis, insiders say. The country expects to count 1 million patients this year, up from 850,000 last year, indicating a recession-proof industry, according to a professor. A supplier of medical products agreed the demand would remain strong, allowing the industry to continue investing in technology and innovations. In general, however, spending decisions are expected to be more cautious because of the financial climate. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067287

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel